NCT03417128

Brief Summary

The outlook of a community-based intervention targeting nutrition and lifestyle behaviour modification among adults with metabolic syndrome (MetS) has not been fully explored. The primary aim of this study (PERSUADE) is to evaluate the effect of the peer support intervention on the clinical outcomes MetS components followed by improvements in the participants' dietary practices, physical activity levels and lifestyle behaviours. The program constructed using information obtained from the published clinical and dietary guideline in Malaysia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2016

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2016

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

December 26, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 31, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

January 31, 2018

Status Verified

January 1, 2018

Enrollment Period

3 years

First QC Date

December 26, 2017

Last Update Submit

January 24, 2018

Conditions

Outcome Measures

Primary Outcomes (6)

  • Changes from baseline waist circumference at post-intervention and 3 months follow-up

    Waist circumference will be measured in centimeters using a body tape.

    Baseline, 3 months, 6 months

  • Changes from baseline systolic blood pressure at post-intervention and 3 months follow-up

    Systolicblood pressure will be expressed in mmHg using an automated blood pressure monitor (OMRON, Japan).

    Baseline, 3 months, 6 months

  • Changes from baseline diastolic blood pressure at post-intervention and 3 months follow-up

    Diastolic blood pressure be expressed in mmHg using an automated blood pressure monitor (OMRON, Japan).

    Baseline, 3 months, 6 months

  • Changes from baseline fasting blood triglyceride levels at post-intervention and 3 months follow-up

    Fasting blood triglyceride levels will be measured in mmol/l using a blood lipid meter (Cardiocheck PA, USA).

    Baseline, 3 months, 6 months

  • Changes from baseline fasting blood HDL-cholesterol levels at post-intervention and 3 months follow-up

    Fasting blood HDL-cholesterol levels will be measured in mmol/l using a blood lipid meter (Cardiocheck PA, USA).

    Baseline, 3 months, 6 months

  • Changes from baseline fasting blood sugar levels at post-intervention and 3 months follow-up

    Fasting blood glucose levels will be measured in mmol/l using a glucometer (B.Braun, Germany).

    Baseline, 3 months, 6 months

Secondary Outcomes (6)

  • Changes from baseline dietary intake at post-intervention and 3 months follow-up

    Baseline, 3 months, 6 months

  • Changes from baseline physical activity levels at post-intervention and 3 months follow-up

    Baseline, 3 months, 6 months

  • Changes from baseline lifestyle behaviour at post-intervention and 3 months follow-up

    Baseline, 3 months, 6 months

  • Changes from baseline health-related quality of life at post-intervention and 3 months follow-up

    Baseline, 3 months, 6 months

  • Changes from baseline body mass index (BMI) at post intervention and 3 months follow-up.

    Baseline, 3 months, 6 months

  • +1 more secondary outcomes

Other Outcomes (3)

  • Intervention Adherence

    3 months

  • Socio-demographic characteristics

    Baseline

  • Intervention Acceptance

    3 months

Study Arms (2)

Control

NO INTERVENTION

Participants in the control group will receive a one-time personalised nutrition and lifestyle advised based from the Malaysian Dietary Guideline 2010. They will be assured to be followed up twice for the next six month.

Peer support

EXPERIMENTAL

This group will receive a continuous three-months, peer-led nutrition and lifestyle behaviour intervention through a series of peer gathering.

Behavioral: Peer support

Interventions

Peer supportBEHAVIORAL

Participants residing in the location selected to be intervene will to form at minimum 4 peer groups. This group will receive a continuous three-months, peer-led nutrition and lifestyle behaviour intervention through a series of peer gathering. Two participants from each peer group will be selected as the peer leader (PL). PL will be trained to deliver the content of PERSUADE modules and will be responsible to run a weekly peer gathering with their respective groups for the following three months.

Peer support

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Physically healthy men and women who are ≥ 18 years old.
  • Literate with a fair command of Bahasa Melayu and/or English.
  • Metabolic syndrome status confirmed according to Harmonised Criteria.
  • Willing to attend weekly peer gathering sessions.

You may not qualify if:

  • Pregnant, lactating or intend to become pregnant during the study period.
  • Diagnosed with Type 1 Diabetes Mellitus (T1DM)
  • Any predisposing condition compromising the quality of life or ability to participate according to protocol.
  • Reported severe complications (chronic heart disease, cerebrovascular disease, diagnosed HIV/AIDS, cancer, emphysema, chronic liver or kidney disease) that would affect the participants' ability to follow the participation in peer activity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Metabolic SyndromeNutritional and Metabolic DiseasesHealth Behavior

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesBehavior

Study Officials

  • Amutha Ramadas, PhD

    Monash University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

December 26, 2017

First Posted

January 31, 2018

Study Start

March 15, 2016

Primary Completion

March 1, 2019

Study Completion

March 1, 2021

Last Updated

January 31, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share